Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas

A consecutive series of 143 unselected adult patients with histologically proved World Health Organization grade II gliomas was reviewed to assess the prognostic value of growth rates of mean tumor diameters on successive magnetic resonance images before treatment. There is an inverse correlation between growth rates and survival (p < 0.001; median survival at 5.16 years for a growth rate of 8mm/year or more; median survival >15.0 years for a growth rate <8mm/year). Thus, individual magnetic resonance imaging tumor growth rates should be incorporated in the planning of the initial therapeutic strategy of grade II gliomas. Ann Neurol 2006;60:380–383

[1]  A. Karim,et al.  Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Kaye,et al.  Low grade glial neoplasms , 2003, Journal of Clinical Neuroscience.

[3]  Pascale Varlet,et al.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria , 1997, Journal of Neuro-Oncology.

[4]  J. Hallervorden.  [Tumors of the nervous system]. , 1951, Strahlentherapie.

[5]  J. Olson.  Neurosurgical advances in the treatment of brain tumors , 2000, Current oncology reports.

[6]  P. Herbison,et al.  Prognostic factors for supratentorial low grade astrocytomas in adults. , 1999, Neurologia medico-chirurgica.

[7]  Olivier Delattre,et al.  Two types of chromosome 1p losses with opposite significance in gliomas , 2005, Annals of neurology.

[8]  F. Langmark,et al.  Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. , 2003, Journal of neurosurgery.

[9]  Robert B. Jenkins,et al.  Losses of Chromosomal Arms 1p and 19q in the Diagnosis of Oligodendroglioma. A Study of Paraffin-Embedded Sections , 2001, Modern Pathology.

[10]  B. Fisher,et al.  Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Daumas-Duport,et al.  Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases , 1997, Journal of Neuro-Oncology.

[12]  R. Makuch,et al.  Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. , 1996, Neurosurgery.

[13]  H. Engler,et al.  Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. , 2001, Cancer.

[14]  B. Fisher,et al.  Ki-67: a prognostic factor for low-grade glioma? , 2002, International journal of radiation oncology, biology, physics.

[15]  D. Louis.  A Molecular Genetic Model of Astrocytoma Histopathology , 1997, Brain pathology.

[16]  David Schiff,et al.  Low-grade gliomas: an update on pathology and therapy , 2005, The Lancet Neurology.

[17]  H. Engler,et al.  Positron emission tomography 11C‐methionine and survival in patients with low‐grade gliomas , 2001 .

[18]  M. Berger,et al.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas , 1994, Cancer.

[19]  Laurent Capelle,et al.  Continuous growth of mean tumor diameter in a subset of grade II gliomas , 2003, Annals of neurology.

[20]  Paul Thompson,et al.  Mapping tumor growth rates in patients with malignant gliomas: A test of two algorithms , 2000, NeuroImage.

[21]  J H Philippon,et al.  Supratentorial low-grade astrocytomas in adults. , 1993, Neurosurgery.